Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of the treatment of neurological diseases to patients worldwide. From Wikipedia
The program introduces a two-phase review model to improve predictability, dovetailing with industry investment pledges ahead of a Sept. 30 stakeholder meeting.
